Five new mononuclear chelate complexes of salicyloylpyrazole oxime ligands with Cd(II) were successfully synthesized. The synthesized complexes were thoroughly characterized using analytical and spectroscopic techniques. All complexes were found to be stable, non-hygroscopic, and amorphous in nature. The measured molar conductance values indicate the non-electrolytic behavior of the complexes. Elemental analysis revealed a 1:2 metal-to-ligand (M:L) stoichiometry for the Cd(II) complexes. The Schiff base ligands act as bidentate chelating agents, coordinating through the imine nitrogen and phenolic oxygen atoms of the salicyloylpyrazole oxime moiety. On the basis of analytical and spectral data, four-coordinate geometry was proposed for all complexes. The electronic absorption spectra further support a tetrahedral geometry around the metal center. The ligand salicyloyl pyrazole oximes and their Cd(II) complexes were screened against Staphylococcus aureus, Bacillus subtilis, Actinomycetes, Klebsiella and Pseudomonas aeruginosa. Thus it can be concluded that most of the ligands and metal complexes posses moderate antimicrobial activity.
A chromogenic spray reagent based on Phosphomolybdic Acid (PMA) is introduced for the selective detection and identification of Monocrotophos, a widely used organophosphate insecticide, through Thin Layer Chromatography (TLC). The reagent, easily prepared by simply dissolving PMA in ethanol. The PMA forms a distinct light purple-pink chromogenic adduct with Monocrotophos. The method demonstrates high selectivity in distinguishing Monocrotophos even in the presence of other organophosphorous insecticides and biological interferences, those found in viscera. The assumption is that the color formation is attributed to a redox mechanism involving the reduction of Mo (VI) to Mo(V). This approach is simple, sensitive, and suitable for forensic toxicological analysis of Monochrotophos in biological and forensic samples.
Due to the increase in global antimicrobial resistance (AMR), there has been a need to create new classes of antibacterials to treat resistant Gram-positive organisms. The first clinically relevant oxazolidinone, linezolid, was a true game changer due to its synthetic nature and novel mechanism of action by targeting initiation of bacterial ribosome formation. Linezolid is believed to have an ant staphylococcal effect by binding to domain V of 23S rRNA within the 50S ribosomal subunit thus preventing formation of the 70S initiation complex. The drug has significant activity against multidrug resistant Gram-positive pathogens, such as methicillin resistant staphylococcus aureus and vancomycin resistant enterococci. Linezolid has very good oral bioavailability, predictable pharmacokinetic parameters, and good tissue penetration; however, prolonged use is associated with the development of myelosuppression, mitochondrial toxicity, and emerging resistance mechanisms due to 23S rRNA mutations and cfr gene methylation. Linezolid is still a major drug of choice for many infections caused by resistant Gram-positive bacteria, but the changes in resistance patterns over time warrant further evaluation of the safety and efficacy of linezolid.
Six Sigma is a structured, data-driven quality management philosophy that has progressively migrated from its origins in electronics and automotive manufacturing into the highly regulated pharmaceutical sector. Its central premise—that any repeatable process can be characterised, controlled and improved so that the rate of defective output approaches 3.4 defects per million opportunities—aligns naturally with the obligations placed on pharmaceutical manufacturers by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the International Council for Harmonisation (ICH). This review provides a critical overview of how Six Sigma, and its hybridised form Lean Six Sigma, is currently applied across the pharmaceutical value chain, with particular emphasis on regulatory affairs. The conceptual foundations of the method are outlined, including the statistical basis of the sigma scale, the DMAIC and DMADV problem-solving frameworks, and the core toolset of statistical process control, design of experiments, failure mode and effects analysis, root-cause analysis, value-stream mapping and process-capability indices. Their integration with established regulatory frameworks such as ICH Q8 (Pharmaceutical Development), ICH Q9 (Quality Risk Management) and ICH Q10 (Pharmaceutical Quality System), and with the Quality-by-Design paradigm, is discussed. Practical applications are examined in active pharmaceutical ingredient manufacturing, formulation and packaging operations, research and development, clinical trial logistics, corrective and preventive action (CAPA) systems and post-marketing surveillance. Recurring implementation barriers, including cultural resistance, deficiencies in data infrastructure and the difficulty of sustaining gains, are critically discussed. The review concludes with a perspective on the convergence of Six Sigma with Industry 4.0 enablers such as process analytical technology, real-time release testing, machine-learning-assisted root-cause analysis and digital quality management systems, which are likely to define the next decade of pharmaceutical operational excellence.
Portable analytical devices have reshaped modern analytical chemistry by enabling fast, on-site testing in healthcare, environmental monitoring, food safety, and related fields. Their mobility, simplicity, and ability to generate real-time results make them valuable for rapid decision-making. This review summarizes key principles, emerging technologies, and recent innovations in portable analytical systems, along with their expanding applications. It also highlights current limitations and future opportunities. Pharmaceutical analysis remains essential for ensuring the safety, quality, and performance of drug products throughout their lifecycle. This article outlines major analytical tools used in pharmaceutical quality control including HPLC, GC, UV-Vis, IR, Raman, NMR, and various physical testing instruments and discusses their role in API quantification, impurity profiling, stability assessment, and content uniformity testing.
